leadf
logo-loader
viewCereno Scientific AB

Cereno Scientific to begin Phase II clinical trial in Bulgaria and Russia to treat thrombosis

Cereno Scientific AB CEO Sten R. Sörensen sat down with Proactive's Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Swedish company, which is listed on the Spotlight Stock Market, is making headway with its thrombosis prevention therapy CS1.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Water Tower Research President talks Energy and how Capstone Turbine is key...

Water Tower Research Co-Founder and President Shawn Severson joined Steve Darling from Proactive to share some insight about the Energy sector and how it is being viewed by users. Severson also told Proactive about Capstone Turbine and some things investors need to watch for from the company...

47 minutes ago

2 min read